Stocktoria

Kodiak Sciences Inc. KOD

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-04 · LEI

Kodiak Sciences Inc. statistics & valuation

Market cap$2.2B
P / B14.3×
Return on equity-146.1%
Return on capital-76.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
201720182019202020212022202320242025
Return on equity (%)
-47.70% -13.70% -15.50% -40.30% -76.50% -98.00% -117.20% -146.10% 201720182019202020212022202320242025
Shares outstanding
39.7M 36.8M 44.4M 51.1M 51.8M 52.3M 52.5M 52.7M 61.8M 201720182019202020212022202320242025
Net debt ($)
201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-861.20% -45.00% -13.20% -12.50% -29.50% -50.10% -54.30% -52.50% -65.40% 201720182019202020212022202320242025
Free cash flow margin (%)
201720182019202020212022202320242025
Debt / equity (×)
201720182019202020212022202320242025
EPS ($)
-$2.91 -$5.16 -$6.39 -$4.97 -$3.35 -$4.32 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-65.4%-52.5%-54.3%-50.1%-29.5%-12.5%-13.2%-45.0%-861.2%
Return on equity-146.1%-117.2%-98.0%-76.5%-40.3%-15.5%-13.7%-47.7%40.6%
Current ratio4.726.726.939.2611.3630.9328.9718.740.17

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.